Margaret Terrell
Family · Athens, ALNPI 1457843245
Payments from drug & device makers
Across 114 payments — averaging $19.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bayer$384
- AstraZeneca$262
- Novartis$228
- Otsuka America Pharmaceutical, Inc.$214
- OPKO Pharmaceuticals, LLC$128
- Ardelyx, Inc.$123
- plus $839 from 15 others
What the payments were for
- Food & beverage$2,178100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bayer | 20 | $384 |
| AstraZeneca | 14 | $262 |
| Novartis | 10 | $228 |
| Otsuka America Pharmaceutical, Inc. | 12 | $214 |
| OPKO Pharmaceuticals, LLC | 7 | $128 |
| Ardelyx, Inc. | 5 | $123 |
| Novo Nordisk | 6 | $117 |
| Pfizer | 6 | $110 |
| Daiichi Sankyo Inc. | 5 | $102 |
| Lilly USA, LLC | 5 | $83 |
| Vifor Pharma, Inc. | 4 | $78 |
| Amgen | 4 | $72 |
| Dexcom, Inc. | 3 | $62 |
| E.r. Squibb & Sons, L.L.C. | 3 | $49 |
| Merck | 3 | $46 |
| Abbott | 2 | $32 |
| GSK | 1 | $24 |
| Akebia Therapeutics Inc | 1 | $20 |
| Johnson & Johnson | 1 | $17 |
| Xeris Pharmaceuticals, Inc. | 1 | $14 |
| Sanofi-aventis U.S. LLC | 1 | $14 |
How this compares
$2,178 in reported general payments places this provider in the 75th percentile of 3,415 family providers in Alabama.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 180 | $122,291 |
| OzempicSemaglutide | 49 | $46,756 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 51 | $39,776 |
| FarxigaDapagliflozin Propanediol | 44 | $30,222 |
| JanuviaSitagliptin Phosphate | 27 | $28,037 |
| JardianceEmpagliflozin | 34 | $27,691 |
| MounjaroTirzepatide | 25 | $25,969 |
| Repatha SureclickEvolocumab | 20 | $18,512 |
| EntrestoSacubitril/Valsartan | 19 | $12,608 |
| BrilintaTicagrelor | 19 | $12,125 |
| TrulicityDulaglutide | 12 | $11,928 |
| TradjentaLinagliptin | 11 | $10,577 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 76 | $10,415 |
| XareltoRivaroxaban | 14 | $9,764 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 15 | $8,855 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $110 | $122,291180 claims |
| Novo NordiskOzempic | $117 | $46,75649 claims |
| AstraZenecaFarxiga, Brilinta | $262 | $42,34863 claims |
| GSKTrelegy Ellipta | $24 | $39,77651 claims |
| Lilly USA, LLCMounjaro, Trulicity | $83 | $37,89737 claims |
| MerckJanuvia | $46 | $28,03727 claims |
| Johnson & JohnsonXarelto, Procrit | $17 | $15,91626 claims |
| NovartisEntresto | $228 | $12,60819 claims |
| Sanofi-aventis U.S. LLCLantus | $14 | $1,63911 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 3,415 family providers in Alabama.
Other family in Athens
- Mona OliveAthens$20K
- Sara WoodAthens$18K
- Justin WilsonCullman$1.1M
- Leigh Ann ChildressHuntsville$240K
- Molly ReevesAuburn$158K
- Christina CanteyHuntsville$118K
- Leigh LunaMontgomery$69K
- Christopher LovellMobile$64K
- Justin SimpsonTuscaloosa$43K
- Kellyn McMahonBirmingham$39K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.